Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention

BACKGROUND: The CYP2C19 nonfunctional genotype reduces clopidogrel effectiveness after percutaneous coronary intervention (PCI). Following clinical implementation of CYP2C19 genotyping at University Florida (UF) Health Shands Hospital in 2012, where genotype results are available approximately 3 day...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Transl Med
Main Authors: Cavallari, Larisa H., Franchi, Francesco, Rollini, Fabiana, Been, Latonya, Rivas, Andrea, Agarwal, Malhar, Smith, D. Max, Newsom, Kimberly, Gong, Yan, Elsey, Amanda R., Starostik, Petr, Johnson, Julie A., Angiolillo, Dominick J.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2018
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5896099/
https://ncbi.nlm.nih.gov/pubmed/29642909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1469-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares